Brain training program aims to restore cognitive function in veterans with long COVID

NCT ID NCT06086379

ENROLLING_BY_INVITATION Symptom relief Sponsor: VA Office of Research and Development Source: ClinicalTrials.gov ↗

First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time

Summary

This study tests a 10-week group program called Compensatory Cognitive Training for COVID-19 (CCT-C) to help veterans with long COVID improve memory, attention, and everyday functioning. Participants are veterans who report cognitive problems after a COVID-19 infection. The program teaches practical strategies to cope with thinking difficulties, and the study compares it to a general health education group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Compensatory Cognitive Training for COVID-19 (CCT-C), a 10-week group behavioral intervention
What this could lead to: If effective, this program could offer a practical, non-drug way to help veterans with long COVID regain cognitive function and independence.
What could go wrong: This is an early-stage trial with only 70 participants, so results may not apply broadly. The control group also receives group support, which may reduce the apparent benefit of the specific training.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POST-ACUTE COVID-19 SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

long COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POST-ACUTE COVID-19 SYNDROME

Contacts and locations

Show contact details

Locations

VA San Diego Healthcare System, San Diego, CA

San Diego, California, 92161-0002, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.